Skip to content

BReLLS: A Prospective Belgian Registry on Laparoscopic Liver Surgery

BReLLS: A Prospective Belgian Registry on Laparoscopic Liver Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03175419
Acronym
BReLLS
Enrollment
1500
Registered
2017-06-05
Start date
2016-02-16
Completion date
2022-12-31
Last updated
2023-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic Liver Surgery

Keywords

laparoscopic liver resection

Brief summary

Setting up a Prospective Belgian National Registry of patients undergoing minimally invasive liver resections will allow the constitution of a national network able to get updated information on indication and results. Data will be of great importance for additional scientific projects aimed to clarify the role of minimally invasive approach in surgical liver pathology, especially malignancies.

Detailed description

During recent years we saw over the world a consistent growth of laparoscopic liver surgery (LLS), essentially due to progress of the surgical techniques, technology and diagnostic imaging. During the Louisville conference on LLS (2008) the technique was thoroughly described and defined. One of the most important statements was the promotion of national registries, taking into account the logistics and feasibility problems of randomized trials in this setting. The main purpose to hold a Belgian national registry is to define the role of LLS in our country, looking for short and long-term outcomes, especially in case of liver tumors. In Belgium approximately 1000 liver resections are performed each year, however, the rate and results of LLS are unknown. The prospective data collection will highlight the role and incidence of LLS. Eventually, the registry will serve as support for scientific projects on different topics. The evolution of the national practice will be measured by looking to the ratio between laparoscopic and open procedures registered in the electronic CRF (eCRF) in a single center during a time period. The registration of additional parameters (as per below) will be necessary for comparing outcomes between conventional and laparoscopic techniques. The registered cases will be recorded prospectively and consecutively.

Interventions

None listed

Sponsors

Medtronic
CollaboratorINDUSTRY
University Hospital, Ghent
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Patients undergoing hepatic resection with minimally invasive approach (laparoscopic and robotic assisted) * minimum age of \> or = 18 years * Signed informed consent. * Cysts deroofing * Laparoscopic resections combined to ablation procedures * Ablation procedures (RFA, MWA, other)

Exclusion criteria

* Laparoscopic staging procedures of the liver with/without intraoperative ultrasonography and/or biopsy. * Solely others therapeutic procedure of the liver (RFA, MWA, PV ligation, etc.)

Design outcomes

Primary

MeasureTime frameDescription
Clavien-dindo grade V24 monthDeath of a patient
Clavien-dindo grade I24 monthAny deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic and radiological interventions.Allowed therapeutic regimens are: drugs as antiemetics, antipyretics, analgetics, diuretics and electrolytes and physiotherapy. This grade also includes wound infections opened at the bedside.
Clavien-dindo grade II24 monthRequiring pharmacological treatment with drugs other than such allowed for grade I complications. Blood transfusions and total parenteral nutrition are also included.
Clavien-dindo grade III A and B24 monthRequiring surgical, endoscopic or radiological intervention, intervention not (A) under general anesthesia; intervention under general anesthesia (B)
Clavien-dindo grade IV24 monthLife-threatening complication (including CNS complications)‡ requiring IC/ICU-management

Secondary

MeasureTime frameDescription
Evolution of the laparoscopic approach24 monthComparison between open and lap procedures in the same center
Assessment of tumor margins24 monthComparison between R0 and R1 margins
Outcome in HCC and CRLM24 monthOverall and disease free survival calculation for the specific above mentioned pathologies
Mortality24 monthIncidence

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026